9 / 50
22
TOBACCO BUSINESS INTERNATIONAL
MAY/JUNE 2015
warning about its potential interaction
with alcohol in light of reports of unusual
or aggressive behavior when drinking
while taking it despite information from
several studies and analyses by Pfizer
that found no difference in psychiatric
problems between people taking Chantix
and other smoking cessation treatments.
However, FDA also said that Pfizer’s
research did not examine all types of
psychiatric problems and had limitations
that prevented regulators “from drawing
reliable conclusions.”
…In a study published on PLOS ONE,
researchers at Duke University and the
University of Connecticut report that
L-menthol, the
menthol isomer
added
to cigarettes, appeared to inhibit smoke-
induced irritation in mice, making it easier
to inhale smoke and increase the dosage
of nicotine.
…A new congressionally-mandated
report fromtheNational ResearchCouncil
and Institute of Medicine states that while
there is insufficient evidence to draw firm
conclusions, limited evidence suggests
that
demand for illegal cigarettes
would not change significantly from
new regulations that modify cigarettes,
such as lowering nicotine content or
making other changes in product design,
formulation and packaging.
…FDA Center for Tobacco Products
will hold the final in a series of three
workshops on
“Electronic Cigarettes
and the Public Health”
on June 1-2,
2015 at the Marriott Inn and Conference
Center at the University of Maryland
University College (UMUC) in Hyattsville,
Maryland. CTP intends to “gather
scientific information and stimulate
discussion among scientists about”
e-cigs, with a focus on the impact of
e-cigs on population health, addressing
topics including: 1) prevalence and
patterns of use; 2) impacts on the use of
current tobacco products; 3) uptake of
e-cigs by non-users of tobacco products;
4) health effects of e-cigs in non-users;
and 5) knowledge, attitudes, beliefs
and perceptions about e-cigs. For more
information, write to workshop.CTPOS@
fda.hhs.gov.
…Professor Michael Siegel of Boston
University’s School of Public Health
said Nate Miley, a member of the Board
of Supervisors for Alameda County,
California, became the first public policy
maker to
publicly back vaping
as a
strategy to combat cigarette smoking by
attending the ribbon-cutting ceremony
for the opening of a new vape store.
At the opening of “Ready, Set, Vape”
in Castro Valley, Miley acknowledged
the controversy surrounding e-cigs but
stressed his support for an intervention
that helps smokers get away from
cigarettes.
…A study by Lorillard researchers
TMA REPORT
On Other tobacco news…
On harm reduction…